{"id":"https://openalex.org/W4213286264","doi":"https://doi.org/10.1200/jco.2022.40.6_suppl.103","title":"Phase 2 trial of immunotherapy in tumors with CDK12 inactivation (IMPACT): Results from cohort A of patients (pts) with metastatic castration resistant prostate cancer (mCRPC) receiving dual immune checkpoint inhibition (ICI).","display_name":"Phase 2 trial of immunotherapy in tumors with CDK12 inactivation (IMPACT): Results from cohort A of patients (pts) with metastatic castration resistant prostate cancer (mCRPC) receiving dual immune checkpoint inhibition (ICI).","publication_year":2022,"publication_date":"2022-02-16","ids":{"openalex":"https://openalex.org/W4213286264","doi":"https://doi.org/10.1200/jco.2022.40.6_suppl.103"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.6_suppl.103","doi":"https://doi.org/10.1200/jco.2022.40.6_suppl.103","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.6_suppl.103","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044876102","display_name":"Ajjai Shivaram Alva","orcid":"https://orcid.org/0000-0002-1898-3522","observed_orcids":["https://orcid.org/0000-0002-1898-3522"]},"institutions":[{"id":"https://openalex.org/I4390039285","display_name":"U-M Rogel Cancer Center","ror":"https://ror.org/05asdy483","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445","https://openalex.org/I4390039285"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ajjai Shivaram Alva","raw_affiliation_strings":["University of Michigan Rogel Cancer Center, Ann Arbor, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan Rogel Cancer Center, Ann Arbor, MI;","institution_ids":["https://openalex.org/I4390039285"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040747167","display_name":"Jinju Li","orcid":"https://orcid.org/0009-0001-4269-9150","observed_orcids":["https://orcid.org/0009-0001-4269-9150"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jinju Li","raw_affiliation_strings":["University of Michigan, Ann Arbor, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan, Ann Arbor, MI;","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019176693","display_name":"Jonathan Chou","orcid":"https://orcid.org/0000-0003-1258-0391","observed_orcids":["https://orcid.org/0000-0003-1258-0391"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Chou","raw_affiliation_strings":["University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033671689","display_name":"Melissa Andrea Reimers","orcid":"https://orcid.org/0000-0002-5167-3630","observed_orcids":["https://orcid.org/0000-0002-5167-3630"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Andrea Reimers","raw_affiliation_strings":["Washington University in St. Louis, St. Louis, MO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University in St. Louis, St. Louis, MO;","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058325420","display_name":"Rana R. McKay","orcid":"https://orcid.org/0000-0002-0581-7963","observed_orcids":["https://orcid.org/0000-0002-0581-7963"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rana R. McKay","raw_affiliation_strings":["University of California San Diego, La Jolla, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Diego, La Jolla, CA;","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083315480","display_name":"Jingsong Zhang","orcid":"https://orcid.org/0000-0003-1192-5116","observed_orcids":["https://orcid.org/0000-0003-1192-5116"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jingsong Zhang","raw_affiliation_strings":["H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016857247","display_name":"Stephanie Daignault\u2010Newton","orcid":"https://orcid.org/0000-0001-6355-0710","observed_orcids":["https://orcid.org/0000-0001-6355-0710"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie Daignault-Newton","raw_affiliation_strings":["University of Michigan, Ann Arbor, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan, Ann Arbor, MI;","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084210416","display_name":"Phillip Lee Palmbos","orcid":"https://orcid.org/0000-0002-3134-2965","observed_orcids":["https://orcid.org/0000-0002-3134-2965"]},"institutions":[{"id":"https://openalex.org/I4390039285","display_name":"U-M Rogel Cancer Center","ror":"https://ror.org/05asdy483","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445","https://openalex.org/I4390039285"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Phillip Lee Palmbos","raw_affiliation_strings":["University of Michigan Rogel Cancer Center, Ann Arbor, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan Rogel Cancer Center, Ann Arbor, MI;","institution_ids":["https://openalex.org/I4390039285"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091728470","display_name":"Zachery Roger Reichert","orcid":"https://orcid.org/0000-0003-0356-8796","observed_orcids":["https://orcid.org/0000-0003-0356-8796"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zachery R Reichert","raw_affiliation_strings":["University of Michigan, Ann Arbor, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan, Ann Arbor, MI;","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051824786","display_name":"Marcin P. Cieslik","orcid":"https://orcid.org/0000-0002-5467-1040","observed_orcids":["https://orcid.org/0000-0002-5467-1040"]},"institutions":[{"id":"https://openalex.org/I4390039285","display_name":"U-M Rogel Cancer Center","ror":"https://ror.org/05asdy483","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445","https://openalex.org/I4390039285"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcin Cieslik","raw_affiliation_strings":["University of Michigan Rogel Cancer Center, Ann Arbor, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan Rogel Cancer Center, Ann Arbor, MI;","institution_ids":["https://openalex.org/I4390039285"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003311852","display_name":"Arul M. Chinnaiyan","orcid":"https://orcid.org/0000-0001-9282-3415","observed_orcids":["https://orcid.org/0000-0001-9282-3415"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arul Chinnaiyan","raw_affiliation_strings":["University of Michigan, Ann Arbor, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan, Ann Arbor, MI;","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062426672","display_name":"Wassim M. Abida","orcid":"https://orcid.org/0000-0002-9006-7043","observed_orcids":["https://orcid.org/0000-0002-9006-7043"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wassim Abida","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"6_suppl","first_page":"103","last_page":"103"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.8842999935150146,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.8842999935150146,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.11180000007152557,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.8460000157356262},{"id":"https://openalex.org/keywords/dual-immune-checkpoint-inhibition","display_name":"dual immune checkpoint inhibition","score":0.7919999957084656},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9779999852180481},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":1.0},{"id":"https://openalex.org/keywords/pd-1-pd-l1-blockade","display_name":"PD-1/PD-L1 blockade","score":0.6439999938011169},{"id":"https://openalex.org/keywords/ctla-4-blockade","display_name":"CTLA-4 blockade","score":0.9850000143051147},{"id":"https://openalex.org/keywords/psa-response","display_name":"PSA response","score":0.6209999918937683},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.6140000224113464},{"id":"https://openalex.org/keywords/tumor-genomic-instability","display_name":"tumor genomic instability","score":0.546999990940094},{"id":"https://openalex.org/keywords/neoantigens","display_name":"neoantigens","score":0.5730000138282776},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.6570000052452087},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.40799999237060547},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.4519999921321869},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.43799999356269836}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8899343609809875},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.771896243095398},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.697258710861206},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.6652217507362366},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6113629341125488},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6057944893836975},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5693422555923462},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4735656976699829},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.46244221925735474},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.4143711030483246},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.362109899520874},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2883872389793396}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.6_suppl.103","doi":"https://doi.org/10.1200/jco.2022.40.6_suppl.103","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.6_suppl.103","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4398783979","https://openalex.org/W2946886341","https://openalex.org/W4402661512","https://openalex.org/W3020145119","https://openalex.org/W7221790034","https://openalex.org/W2808021061","https://openalex.org/W4412705201","https://openalex.org/W4393989154","https://openalex.org/W3008168317","https://openalex.org/W2889640189"],"abstract_inverted_index":{"103":[0],"Background:":[1],"Prostate":[2],"cancer":[3,345],"with":[4,34,75,86,201,314],"CDK12":[5,37,58,94],"inactivation":[6,38,59,95],"represents":[7],"a":[8,48,163,291,319],"distinct":[9],"subtype":[10],"in":[11,36,57,68,171,197,208,215,259,267,278,283,306,318,331,343],"mCRPC,":[12],"tumors":[13],"are":[14,346],"characterized":[15],"by":[16,138,295],"excessive":[17],"tandem":[18],"duplications,":[19],"genomic":[20],"instability,":[21],"gene":[22],"fusion-caused":[23],"putative":[24,93],"neoantigens":[25],"and":[26,43,55,92,125,184,195,249,263,281,311,337],"increased":[27],"tumor":[28,111,191],"T":[29],"cell":[30],"infiltration.":[31],"Retrospective":[32],"experiences":[33],"ICI":[35],"CRPC":[39],"pts":[40,79,213,240,261,269,285,288],"reported":[41],"PSA":[42,159,172,232,254,264,293,316],"radiographic":[44],"responses.":[45],"We":[46],"conducted":[47],"prospective":[49],"multi-site":[50],"clinical":[51],"trial":[52,350],"of":[53,73,96,205,321,334,340],"ipilimumab":[54,126],"nivolumab":[56,121,140,341],"or":[60,102,152,166],"mutated":[61],"cancers.":[62],"Herein,":[63],"we":[64],"report":[65],"our":[66],"findings":[67],"the":[69],"completed":[70],"cohort":[71],"A":[72],"men":[74],"mCPRC.":[76],"Methods:":[77],"Eligible":[78],"had":[80,226,241],"mCRPC":[81,212],"(ongoing":[82],"androgen":[83,246],"deprivation":[84],"therapy":[85],"serum":[87],"testosterone":[88],"\u00a3":[89],"50":[90],"ng/dL)":[91],"function":[97],"aberrations":[98],"on":[99],"any":[100],"commercial":[101],"institutional":[103],"CLIA/CAP":[104],"approved":[105],"next":[106],"generation":[107],"sequencing":[108],"assay.":[109],"Archival":[110],"tissue":[112],"was":[113,158,221,236,257,303,312],"requested":[114],"for":[115,132],"correlative":[116,324],"biomarker":[117],"analysis.":[118],"Pts":[119],"received":[120,242],"3":[122],"mg/kg":[123,128],"IV":[124,129,144],"1":[127,222],"q3":[130],"weeks":[131,146],"up":[133],"to":[134,168],"4":[135],"cycles,":[136],"followed":[137],"maintenance":[139],"at":[141,233],"480":[142],"mg":[143],"q4":[145],"until":[147],"disease":[148],"progression,":[149],"intolerable":[150],"toxicity,":[151],"consent":[153],"withdrawal.":[154],"The":[155],"primary":[156],"endpoint":[157],"response,":[160],"defined":[161],"as":[162],"greater":[164],"than":[165],"equal":[167],"50%":[169],"decline":[170,256,266],"from":[173],"baseline.":[174,299],"Secondary":[175],"endpoints":[176],"included":[177,189],"safety/toxicity,":[178],"secondary":[179],"efficacy":[180],"measures":[181],"including":[182],"QoL":[183],"overall":[185],"survival.":[186],"Exploratory":[187],"objectives":[188],"baseline":[190,231],"whole":[192],"exome":[193],"analysis":[194],"changes":[196],"circulating":[198],"immune":[199],"profiles":[200],"therapy.":[202],"Results:":[203],"As":[204],"data":[206],"cut-off":[207],"Aug":[209],"2021,":[210],"28":[211],"enrolled":[214],"Cohort":[216,332,338],"A;":[217],"median":[218],"ECOG":[219],"PS":[220],"(0-2":[223],"range),":[224],"22/28":[225],"Gleason":[227],"8-10":[228],"cancer,":[229],"mean":[230],"study":[234],"entry":[235],"231":[237],"ng/dL,":[238],"all":[239],"\u22651":[243,250],"prior":[244],"oral":[245],"signaling":[247],"inhibitor":[248],"cytotoxic":[251],"chemotherapy.":[252],"Unconfirmed":[253],"\u226530%":[255],"seen":[258],"6/28":[260],"(21.4%)":[262,289],"\u226550%":[265],"4/28":[268],"(14.2%).":[270],"Grade":[271],"\u22653":[272],"possible/probable/definite":[273],"adverse":[274],"events":[275],"were":[276],"noted":[277],"7/28":[279],"(25%)":[280],"SAEs":[282],"10/28":[284],"(35.7%).":[286],"Six":[287],"experienced":[290],"rapid":[292],"increase":[294],"\u2265":[296],"10-fold":[297],"over":[298],"Conclusions:":[300],"Combination":[301],"immunotherapy":[302],"reasonably":[304],"tolerated":[305],"this":[307],"heavily":[308],"pre-treated":[309],"population":[310],"associated":[313],"unconfirmed":[315],"responses":[317,328],"subset":[320],"pts.":[322],"Ongoing":[323],"analyses":[325],"could":[326],"explain":[327],"mechanistically.":[329],"Enrollment":[330],"B":[333],"non-prostate":[335],"cancers":[336],"C":[339],"monotherapy":[342],"prostate":[344],"still":[347],"ongoing.":[348],"Clinical":[349],"information:":[351],"NCT03570619.":[352]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-02-24T00:00:00"}